相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and Dietary Management
Vijayakumar Natesan et al.
BIOMOLECULES & THERAPEUTICS (2021)
A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate
Dian Xiao et al.
THERANOSTICS (2021)
Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids
Rebecca Borella et al.
MOLECULES (2019)
Cleavable linkers in antibody-drug conjugates
Jonathan D. Bargh et al.
CHEMICAL SOCIETY REVIEWS (2019)
Modelling diabetic nephropathy in mice
Kengo Azushima et al.
NATURE REVIEWS NEPHROLOGY (2018)
Identification of a Novel Hybridization from Isosorbide 5-Mononitrate and Bardoxolone Methyl with Dual Activities of Pulmonary Vasodilation and Vascular Remodeling Inhibition on Pulmonary Arterial Hypertension Rats
Yusheng Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy
Zhangjian Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and biological evaluation of amino acid methyl ester conjugates of 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid against the production of nitric oxide (NO)
Evans O. Onyango et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl
Melanie P. Chin et al.
JOURNAL OF CARDIAC FAILURE (2014)
Diabetic nephropathy - complications and treatment
Andy K. H. Lim
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2014)
New targets for treatment of diabetic nephropathy: what we have learned from animal models
Frank C. Brosius et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Bardoxolone methyl analogs RTA 405 and dh404 are well tolerated and exhibit efficacy in rodent models of Type 2 diabetes and obesity
Melanie Chin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Development of Novel Bisphosphonate Prodrugs of Doxorubicin for Targeting Bone Metastases That Are Cleaved pH Dependently or by Cathepsin B: Synthesis, Cleavage Properties, and Binding Properties to Hydroxyapatite As Well As Bone Matrix
Katrin Hochdoerffer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles
Iana M. Serafimova et al.
NATURE CHEMICAL BIOLOGY (2012)
Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease
Karen T. Liby et al.
PHARMACOLOGICAL REVIEWS (2012)
Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models
Asaf A. Qureshi et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Oxidative stress in early diabetic nephropathy: fueling the fire
Dhruv K. Singh et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Proteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to mTOR
Mark M. Yore et al.
PLOS ONE (2011)
The azaquinone-methide elimination: comparison study of 1,6-and 1,4-eliminations under physiological conditions
Rotem Erez et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes
Melinda S. Yates et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Triterpenoid CDDO-Me blocks the NF-κB pathway by direct inhibition of IKKβ on Cys-179
Rehan Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy
Holger Schmid et al.
DIABETES (2006)
hERG potassium channels and cardiac arrhythmia
MC Sanguinetti et al.
NATURE (2006)
A synthetic triterpenoid, CDDO-Me, inhibits IκBα, kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor κB-regulated gene products in human leukemic cells
S Shishodia et al.
CLINICAL CANCER RESEARCH (2006)
Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress
AT Dinkova-Kostova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
